InvestorsHub Logo
Followers 32
Posts 2803
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Friday, 04/30/2021 10:10:01 PM

Friday, April 30, 2021 10:10:01 PM

Post# of 28
Longer term data from the ALLO-501 PhI (ALPHA) trial will be presented alongside initial data from the PhI ALLO-501A (ALPHA2) trial at ASCO. There will be a separate presentation on ALLO-647, to include safety and PK/PD data

ALLO-501A, is intended for a potentially pivotal PhII trial, which should start in 2H, Previously it has been granted FDA fast track for R/R DLBCL. The company will host a webcast to review the data sets on May 19, at 2:30 pm PT/5:30 pm ET.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALLO News